Organizing Pneumonia in Hospitalized COVID-19 Patients: Risk Factors and Long-term Outcomes
mayo 24, 2024
Some patients develop post-COVID organizing pneumonia (OP), which is responsiveto treatment with corticosteroids.
Some patients develop post-COVID organizing pneumonia (OP), which is responsiveto treatment with corticosteroids.
In the general population Persistent Airflow Obstruction (PAO) was largely mild but there are significant phenotypic differences between young and old individuals with PAO
Uncover the prevalence, characteristics, and comorbidities of asthma with airflow obstruction (AFO) in adults over 50. Learn how AFO compares to asthma-only and COPD-only in this comprehensive study.
Lung-function development can be altered by several host and environmental factors during the life course. As a result, a range of lung-function trajectories exist in the population.
We explore this concept and look at atopic dermatitis, chronic rhinosinusitis with nasal polyps, etc., as treatable traits of asthma and how these can be managed.
Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases.
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.
COPD is a common, preventable, and treatable disease, but extensive under-diagnosis and misdiagnosis leads to patients receiving no treatment or incorrect treatment.
The Global Burden of Disease Study 2017 identified that a country’s sociodemographic index was a key factor affecting mortality and loss of health from respiratory diseases.
COPD is the elephant in the room for many patients with CVDs.